The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study

Sponsor
Sindh Institute of Urology and Transplantation (Other)
Overall Status
Completed
CT.gov ID
NCT05463276
Collaborator
(none)
690
1
2
338.7

Study Details

Study Description

Brief Summary

This cross-sectional study, conducted at the Sindh Institute of Urology and Transplantation (SIUT), involved a retrospective data review of all the patients diagnosed with breast cancer from March 2017 to December 2021. The demographic characteristics, clinical presentation, stage of the disease, and histopathological characteristics were analyzed.

Study Design

Study Type:
Observational
Actual Enrollment :
690 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
Actual Study Start Date :
Feb 28, 2022
Actual Primary Completion Date :
May 1, 2022
Actual Study Completion Date :
May 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients with breast cancer

Outcome Measures

Primary Outcome Measures

  1. Demographic characteristics of patients with breast cancer [At the time of presentation]

    age, gender, residence, marital status

  2. Risk factors of patients with breast cancer [At the time of presentation]

    age at menarche, menopause, parity, breastfeeding, contraception, family history, body mass index

  3. Clinical presentation of patients with breast cancer [At the time of presentation]

    site and duration

  4. Stage of the breast cancer [At the time of presentation]

    American Joint Committee on Cancer (AJCC) Anatomic Stage Groups for breast cancer

  5. Histopathological characteristics of patients with breast cancer [At the time of presentation]

    tumor type, hormone receptor status, Ki-67, and grade

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients diagnosed with breast cancer
Exclusion Criteria:
  • The patients that were lost to follow-up after the first consultation and those consulting for a second opinion were excluded from the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sindh Institute of Urology and Transplantation Karachi Sindh Pakistan

Sponsors and Collaborators

  • Sindh Institute of Urology and Transplantation

Investigators

  • Principal Investigator: Murk Niaz, Sindh Institute of Urology and Transplantation
  • Principal Investigator: Bushra Shirazi, Sindh Institute of Urology and Transplantation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Murk Niaz, Medical Officer, Sindh Institute of Urology and Transplantation
ClinicalTrials.gov Identifier:
NCT05463276
Other Study ID Numbers:
  • Breast Audit
First Posted:
Jul 18, 2022
Last Update Posted:
Jul 21, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Murk Niaz, Medical Officer, Sindh Institute of Urology and Transplantation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2022